PATENT CLAIM ANALYSIS

Application Number: 16215340
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["514", "389000"]

Abstract:
Methods for treating triple negative breast cancer with an androgen receptor inhibitor are provided, as well as methods for screening for the likelihood of the effectiveness of such treatment.

Claim (Index 31):
The method according to  claim 25 , wherein the breast cancer treatment is administered if the Basal Centroid classifier score is less than or equal to 0.6.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 98.0
- Lexical Diversity: 1.19231
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14962864', '15075373', '13421367', '14759889', '12995450']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7164526385443453
- 35 USC 102 Novelty (BERT): 0.7301163867438359
- Combined Prediction Score: 0.7178190133642943
- Mean Citation Score: 429.173646
- Max Citation Score: 886.7025
- Similarity Product: 780.0584609708189

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test